一个灵活的模块化杀虫剂释放平台通过聚氨尿素微囊:不同交叉连接剂组成的影响
Jian Wang1, Zefeng Shi1, Guohui Yuan2
1Shanghai Engineering Research Center of Green Energy Chemical Engineering, The Key Laboratory of Resource Chemistry of Ministry of Education, College of Chemistry and Materials Science, Shanghai Normal University, Shanghai, P. R. China.
Pest management science
|March 9, 2024
概括
研究人员通过各种交叉链接器开发了含有埃玛麦丁酸的聚氨尿素 (PU-MC) 微囊. 不同的交叉连接剂组合显著改变了PU-MC的特性,包括外厚度,封装效率和释放率,优化了农药的输送.
科学领域:
- 材料科学 材料科学 材料科学
- 聚合物化学 聚合物化学
- 农业化学 农业化学
背景情况:
- 聚合物微囊 (MCs) 为各种应用提供可调节的性能.
- 在MC中不同的外结构可以赋予多个功能.
研究的目的:
- 为了合成含有埃玛丁酸 (EB) 的聚氨尿素微囊 (PU-MCs).
- 研究不同交叉连接器对PU-MC特性和性能的影响.
- 优化农药输送系统,以提高利用率和降低毒性.
主要方法:
- 使用界面聚合来制造PU-MCs.
- 各种多 (1,4-butanediol,甘油) 和多氨酸 (三乙烯二胺,异二胺) 被用作交叉链接剂.
- 描述包括显微镜,封装效率,药物加载,释放研究,热分析和生物试验.
主要成果:
- PU-MCs表现出球形形态,尺寸在500-700nm之间.
- 交叉连接器的选择影响了外厚度,封装效率和释放动力学.
- BT-MCs显示出最快的释放和良好的杀虫活性对抗Plutella xylostella.
- 观察到增强的热和光稳定性,表明持续释放潜力.
结论:
- 通过交叉连接器选择制造有效调节EB-加载PU-MC属性.
- 这种方法为构建先进的农药输送系统提供了一条途径.
- 优化的PU-MC可以提高农药利用率,并可能最大限度地降低毒性.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
139
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
139
Modified-Release Drug Delivery Systems: Drug Release Characteristics
263
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
263
Modified-Release Drug Delivery Systems: Classification
318
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
318
Modified-Release Drug Delivery Systems: Rate-Programmed I
174
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
174
Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


